A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults (Part 1)
Status:
Completed
Trial end date:
2017-03-09
Target enrollment:
Participant gender:
Summary
This is a single center, randomized, double-blind, dose-escalation, placebo-controlled phase
1 clinical trial. This study will determine the safety and side-effect profile of an
investigational dexlansoprazole injection after single intravenous administration in healthy
Chinese adults.